eTumorMetrics software improves accuracy, efficiency, and analytics in clinical trials and clinical care.
ePET™ is complimentary to eMASS™, utilizing computer-assisted tumor response evaluation. However, ePET™ will have the ability to fuse and evaluate PET CT and PET MR images.
Facilitates evaluation of FDG PET CT/MRI
Optionally adheres to the rules of commonly used oncologic objective response criteria (e.g. PERCIST, Lugano, Deauville, etc.)
Captures a variety of PET metrics (e.g. SUV, SUL, MTB, TGV, etc.)
Provides key images and graphs
Includes tables that display objective response and quantitative PET metrics
A commercial version of ePET™ is currently in design phase and will soon be under development and will undergo testing in preparation for FDA 510(k) clearance in 2019.